VVN539

· VivaVision Biotech, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VVN539, covering 2024-01-17 to 2024-01-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure [Phase 2]